Dr Froeling's work focuses on profiling pancreatic tumours to look for clues that will help match patients to the most effective epigenetic drugs available.
Dr Costello's team is looking for ways to block a particular protein that pancreatic cancers cells can use to protect themselves against drugs.
Dr Cornelissen is developing ways of using PET imaging to detect early stage pancreatic cancer.
Dr Wang is investigating ways to combine virotherapy approaches with immune system-boosting drugs to kill any remaining pancreatic cancer cells post-surgery.
Dr Schmid's research explores how white blood cells help pancreatic cancer cells to spread and grow new tumours.
Professor Machesky is investigating drug compounds that affect a protein called fascin1, thought to help pancreatic cancer cells move and spread.
This research looks at ways to block the chemical messaging between pancreatic cancer cells and stellate cells which helps the cancer to invade neighbouring healthy tissue.
Dr Kermorgant is investigating drug compounds that could curb the action of a molecule called c-Met, which triggers the spread of pancreatic cancer.
Dr Forde is evaluating the potential for short electric pulses to increase the uptake of chemotherapy drugs by pancreatic cancer cells.
Dr Bruce is exploring ways to cut off the energy supply used by pancreatic cancer cells to pump calcium out of the cells.